It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

33

M/SUNNY

TOKYO (6 p.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Johnson & Johnson

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Drugmakers pause trials in Russia while still sending medicine

Business Mar 15, 2022

Drugmakers pause trials in Russia while still sending medicine

by Riley Griffin and Robert Langreth

Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.

Japan to accept Johnson & Johnson COVID vaccine for border entry next month

National Feb 24, 2022

Japan to accept Johnson & Johnson COVID vaccine for border entry next month

The J&J shot, which has not been approved in Japan, will join a list of three other shots that have been approved by regulators as sufficient for nonresidents to enter.

Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims

World | FOCUS Feb 5, 2022

Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims

by Mike Spector and Dan Levine

If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products or misconduct.

Breakups usher in a new era of corporate conglomerates

Business | FOCUS Nov 16, 2021

Breakups usher in a new era of corporate conglomerates

by Matthew Boyle, Jeff Green and Ryan Beene

Activists and corporate governance advocates cheered splits by GE, J&J and Toshiba, but tech firms have been driving unrelated transactions, creating what are called "neoconglomerates.”

Pharmaceutical firms rake in billions with COVID-19 shots

Business / Corporate Aug 10, 2021

Pharmaceutical firms rake in billions with COVID-19 shots

Pfizer has earned more than its competitors, raking in $10.8 billion in the first half of this year.

South African study shows high protection from Johnson & Johnson shot

World Aug 7, 2021

South African study shows high protection from Johnson & Johnson shot

The country's health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer's.

Johnson & Johnson seeks COVID-19 vaccine approval in Japan

National May 25, 2021

Johnson & Johnson seeks COVID-19 vaccine approval in Japan

The company said that, once approval of its one-shot COVID-19 vaccine is given, it could begin supplying doses to the country in early 2022.

U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately

World Apr 24, 2021

U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately

Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.

Why the vaccine safety numbers are still fuzzy

World / Science & Health Apr 17, 2021

Why the vaccine safety numbers are still fuzzy

by Margot Sanger-Katz and Alicia Parlapiano

If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.

The FDA’s caution on the J&J vaccine is a costly mistake

Commentary / World Apr 14, 2021

The FDA’s caution on the J&J vaccine is a costly mistake

by Karl W. Smith

The FDA acted after blood clots were observed in less than one in a million people who have received the J&J vaccine. COVID-19 has already killed 1,712 out of every million Americans.

Vaccine blood-clot side effect puts focus on immune reaction

World / Science & Health Apr 14, 2021

Vaccine blood-clot side effect puts focus on immune reaction

by John Lauerman and Robert Langreth

Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

World Apr 13, 2021

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

by Noah Weiland, Sharon Lafraniere and Carl Zimmer

The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Lost USB memory sticks with data on Japanese city's residents found
    Amagasaki Mayor Kazumi Inamura speaks during a news conference on Thursday.
  • Missing boat that brought North Korean fishermen to Akita coast found on seabed
    A fishing boat that washed ashore with eight North Korean men aboard is seen Friday in Yurihonjo, Akita Prefecture. The boat, which disappeared on Saturday, has been found on the seabed.
  • Japanese city loses memory drive with information on all 460,000 residents
    Officials of Amagasaki, Hyogo Prefecture, apologize for losing a USB flash drive with residents' personal information during a news conference on Thursday.
  • Police get serious with preparations for possible Mount Fuji eruption
    Japan's Mount Fuji is seen covered with snow from an airplane. The National Police Agency has started making full-fledged preparations for a possible eruption of the country's tallest peak.
  • Totoro's home: Japan crowdfund for forest that inspired film
    The first Totoro Forest area in Tokorozawa, Saitama Prefecture, acquired in 1991 by the use of donated funds
  • China's Xi to attend Hong Kong anniversary event

    Thumbnail image
  • Global warming leading to sleep loss and wider disparities

    Thumbnail image
  • Abortion pills over the counter? Experts see big hurdles in widening U.S. access.

    Thumbnail image
  • Japan begins return to business-as-usual at big events — but slowly

    Thumbnail image
  • Sapporo U.S.A. to acquire Stone Brewing as it moves to speed up global expansion

    Thumbnail image

PODCAST

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times